| Literature DB >> 26906964 |
Francesc Graus1, Maarten J Titulaer2, Ramani Balu3, Susanne Benseler4, Christian G Bien5, Tania Cellucci6, Irene Cortese7, Russell C Dale8, Jeffrey M Gelfand9, Michael Geschwind9, Carol A Glaser10, Jerome Honnorat11, Romana Höftberger12, Takahiro Iizuka13, Sarosh R Irani14, Eric Lancaster3, Frank Leypoldt15, Harald Prüss16, Alexander Rae-Grant17, Markus Reindl18, Myrna R Rosenfeld19, Kevin Rostásy20, Albert Saiz21, Arun Venkatesan22, Angela Vincent14, Klaus-Peter Wandinger23, Patrick Waters14, Josep Dalmau24.
Abstract
Encephalitis is a severe inflammatory disorder of the brain with many possible causes and a complex differential diagnosis. Advances in autoimmune encephalitis research in the past 10 years have led to the identification of new syndromes and biomarkers that have transformed the diagnostic approach to these disorders. However, existing criteria for autoimmune encephalitis are too reliant on antibody testing and response to immunotherapy, which might delay the diagnosis. We reviewed the literature and gathered the experience of a team of experts with the aims of developing a practical, syndrome-based diagnostic approach to autoimmune encephalitis and providing guidelines to navigate through the differential diagnosis. Because autoantibody test results and response to therapy are not available at disease onset, we based the initial diagnostic approach on neurological assessment and conventional tests that are accessible to most clinicians. Through logical differential diagnosis, levels of evidence for autoimmune encephalitis (possible, probable, or definite) are achieved, which can lead to prompt immunotherapy.Entities:
Mesh:
Year: 2016 PMID: 26906964 PMCID: PMC5066574 DOI: 10.1016/S1474-4422(15)00401-9
Source DB: PubMed Journal: Lancet Neurol ISSN: 1474-4422 Impact factor: 44.182